Compound ID | 735
Class: Oxazolidinone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Protein 30S ribosomal subunit inhibitors; activity against S. pneumoniae and S. aureus |
Institute where first reported: | Pharmacia &Upjohn ; Pharmacia Corp.; Pfizer, USA |
Year first mentioned: | 1999 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citation: |